T1/T2 Research (Bedside/Bench)

T1/T2; developing therapeutic strategies targeted to patient and cancer biomarkers. A translational research program linking the biosciences, clinical trials and individualising care.

T1 Research

Sydney Catalyst will link basic sciences discoveries, with novel early phase clinical trials through to better personalised patient care. We will identify subpopulations of patients who will benefit most from particular treatment by using in vitro diagnostics to determine their molecular phenotype individual cancer to guide therapeutic decisions. Laboratory assays will be linked to patient cohorts within our hospitals and with ongoing and future controlled trials.

Details of Sydney Catalyst funded T1/T2 research to date can be found in the links below:

To read about projects that cross both the T1/T2 and T2/T3 research streams click here.